MedTrace Logo

Psychosocial Factors and Quality of Life in the Effect of Fear of COVID-19 With Cystic Fibrosis

NCT05195216 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2022-01-18

No results posted yet for this study

Summary

The purpose of this study; The COVID-19 pandemic is to investigate the effects of COVID-19 fear levels of patients with cystic fibrosis on the psychosocial and quality of life levels of individuals.

Conditions

Interventions

BEHAVIORAL

Survey Form, The Hospital Anxiety and Depression Scale, The Fear of COVID-19 Scale,World Health Organization Quality of Life Scale- Bref Form

Online questionnaires were administered to individuals.

Sponsors & Collaborators

  • Elif Kabasakal

    lead OTHER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-20
Primary Completion
2021-11-30
Completion
2021-12-25

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05195216 on ClinicalTrials.gov